MINNEAPOLIS, Oct. 22, 2013 (GLOBE NEWSWIRE) -- OnPoint Medical Diagnostics (OTCQB:ONMD) announced today it has signed a contract with Children's Hospital of Philadelphia (CHOP) to provide OnPoint's MRI Quality Assurance (QA) software. The five-year agreement is effective July 2013 and runs through June of 2018.
CHOP currently manages eight MRI scanners accredited through the American College of Radiology, which are located throughout the main hospital campus as well as an outpatient diagnostic center located in western Philadelphia, PA. OnPoint's QA software eliminates the need for paper, provides automatic email alerts when problems are detected and provides web access to required reports for the team.
"We are really excited to partner with Children's Hospital of Philadelphia and help take their QA program to the next level," said Ken Roos, Chief Revenue Officer at OnPoint Medical Diagnostics. "Having recently earned the top spot on US News World and Report's 2013-2014 Honor Roll, it's yet another example of their commitment to providing the highest level of quality care for their patients every single day".
OnPoint has successfully tested over 150,000 MRI QA images from over 150 MRI scanners across 22 states using its cloud-based quality assurance technology. In addition, it is currently working with industry thought leaders to leverage its big-data medical imaging platform to provide objective and measurable quality to other areas of medical imaging. For more information, visit www.onpointmd.com.
About OnPoint Medical Diagnostics
OnPoint's big-data medical imaging platform assists the global healthcare industry in delivering the highest quality medical images possible – safely, consistently and efficiently. Its solutions are deployed in the cloud and delivered in a SaaS framework, which provides anytime, anywhere access to the technology. The company's flagship product for MRI is focused on automating the quality control measures required for accreditation by the American College of Radiology, with real-time dashboards, analytics and trending to make sure scanners are providing the best possible images of patients. For more information, visit www.onpointmd.com.
Notice Regarding Forward-Looking Statements
In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the company's current expectations or forecasts of future events. The company's performance and financial results could differ materially from those reflected in these forward-looking statements due to risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to: our ability to react to trends and challenges in our business and the markets in which we operate; our ability to anticipate market needs or develop new or enhanced products to meet those needs; the adoption rate of our products; our ability to establish and maintain successful relationships with our collaboration partners; our ability to compete in our industry; fluctuations in demand, sales and prices for our products and services; our ability to protect our intellectual property rights; our ability to limit liability for claims against our predecessor or as a result of our restructuring; general political, economic and market conditions and events; and other risks and uncertainties described more fully described in our documents filed with or furnished to the Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. The company undertakes no obligation to update publicly any forward-looking statement.